{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:37:32Z","timestamp":1761975452636},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.2146\/ajhp130474","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T09:53:25Z","timestamp":1408614805000},"page":"1457-1461","source":"Crossref","is-referenced-by-count":22,"title":["A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline"],"prefix":"10.1093","volume":"71","author":[{"given":"Felix K.","family":"Yam","sequence":"first","affiliation":[{"name":"Felix K. Yam, Pharm.D., M.A.S., BCPS, is Assistant Clinical Professor of Pharmacy, University of California (UC) San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla. Brian K. Kwan, M.D., is Assistant Clinical Professor of Medicine, UC San Diego School of Medicine, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Felix K. Yam, Pharm.D., M.A.S., BCPS, is Assistant Clinical Professor of Pharmacy, University of California (UC) San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla. Brian K. Kwan, M.D., is Assistant Clinical Professor of Medicine, UC San Diego School of Medicine, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019031208575711100_b1-0711457","volume-title":"Teflaro (ceftaroline fosamil) package insert","year":"2012"},{"key":"key\n\t\t\t\t2019031208575711100_b2-0711457","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1592\/phco.30.4.375","article-title":"Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens","volume":"30","author":"Steed","year":"2010","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019031208575711100_b3-0711457","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/AAC.00590-07","article-title":"Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections","volume":"51","author":"Talbot","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208575711100_b4-0711457","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10156-012-0449-9","article-title":"The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients","volume":"19","author":"Lin","year":"2013","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t2019031208575711100_b5-0711457","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208575711100_b6-0711457","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019031208575711100_b7-0711457","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.1986.tb02944.x","article-title":"Cephalosporin-induced neutropenia","volume":"62","author":"Neftel","year":"1986","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019031208575711100_b8-0711457","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1985.tb02957.x","article-title":"Cephalosporin-induced immune neutropenia","volume":"59","author":"Murphy","year":"1985","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019031208575711100_b9-0711457","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/infdis\/152.1.90","article-title":"Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics","volume":"152","author":"Neftel","year":"1985","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031208575711100_b10-0711457","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/030098588802500305","article-title":"Cephalosporin-induced changes in the ultrastructure of canine bone marrow","volume":"25","author":"Deldar","year":"1988","journal-title":"Vet Pathol"},{"key":"key\n\t\t\t\t2019031208575711100_b11-0711457","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/25.3.449","article-title":"A prospective study of neutropenia induced by high doses of beta-lactam antibiotics","volume":"25","author":"Olaison","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208575711100_b12-0711457","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.1983.tb01233.x","article-title":"Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia","volume":"55","author":"Murphy","year":"1983","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019031208575711100_b13-0711457","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002018-200730040-00002","article-title":"Systematic review of piperacillin-neutropenia","volume":"30","author":"Scheetz","year":"2007","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019031208575711100_b14-0711457","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/ajhp\/60.21.2229","article-title":"Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis","volume":"60","author":"Wong","year":"2003","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019031208575711100_b15-0711457","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jcpt.12062","article-title":"Ceftaroline\u2014a cause for neutropenia","volume":"38","author":"Rimawi","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t2019031208575711100_b16-0711457","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/17\/1457\/28048807\/ajhp1457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T09:46:16Z","timestamp":1552383976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/17\/1457\/5110959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":16,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130474","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,9,1]]},"published":{"date-parts":[[2014,9,1]]}}}